Point-of-Care Monitoring of Anticoagulation Therapy, 1st Edition
This document provides guidance to users and manufacturers of point-of-care coagulation devices for monitoring heparin and warfarin anticoagulant therapy, and to ensure reliable results comparable to those obtained by routine clinical laboratory testing.
This document is available in electronic format only.
Member pricing between $42.00 and $119.00Nonmember Price: $140.00
Chairholder: Bruce H. Davis, MD and Samuel J. Machin, MB, ChB, FRCPath, FRCP
Date of Publication: July 1, 2004
ISBN Number: 1-56238-540-2
Order Code PDF: POCT14AE
Order Code Print: print not available
POCT14 Additional Details
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus standard for use in satisfying a regulatory requirement.
This document is included in the CLSI document code change and rebranding that is currently in process. This code has changed from H49-A to POCT14-A. Please make sure that the document title corresponds to the publication that you intend order.